It may very well be a 'low volume' week, but considering the importance of getting the trials started, I really don't think they would hold on to that news until next week if they had the FDA nod of approval. Perhaps they've moved the goal post and are just not saying anything.
Now that we are in Sept, what would a reasonable timeframe look like for trial goals for the rest of the year?
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links